Financhill
Back

CytoSorbents Stock Predictions

CytoSorbents Stock Forecast

  • Is CytoSorbents Stock Undervalued?
    The current CytoSorbents [CTSO] share price is $0.92. The Score for CTSO is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • CTSO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will CytoSorbents Stock Go Up Next Year?

Data Unavailable

CytoSorbents Stock Rating

Data Unavailable

CytoSorbents Stock Price History

Is CTSO stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTSO is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
cytosorbents.com

52-Week Data

52-Week High:
2.15
52-Week Low:
0.70

Prediction Charts

Market Cap:
50.08M
Price in USD:
0.92
Volume:
102.2K
Beta:
-0.46

Technical Analysis

SMA50:
1.12
SMA100:
1.07
SMA200:
0.99
52-Wk Change:
-34.58%

Stock Predictions

  • Is CytoSorbents stock public?
    Yes, CytoSorbents is a publicly traded company.
  • What is the CytoSorbents stock quote today?
    The CytoSorbents stock price is 0.92 USD today.
  • How to buy CytoSorbents stock online?
    You can buy CytoSorbents shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-1 1.00 1.00 1.03 0.98
Nov-4 1.00 0.87 1.00 0.87
Nov-5 0.92 0.86 0.92 0.86
Nov-6 0.99 0.92 0.99 0.85
Nov-7 0.95 0.90 0.96 0.90
Nov-8 0.89 0.74 0.95 0.71
Nov-11 0.82 0.94 0.97 0.80
Nov-12 0.95 0.97 1.04 0.90
Nov-13 1.00 0.93 1.04 0.93
Nov-14 0.92 0.95 0.99 0.92
Nov-15 0.94 0.90 1.00 0.90
Nov-18 0.90 0.93 0.97 0.90
Nov-19 0.93 0.96 0.96 0.92
Nov-20 0.93 0.92 0.97 0.91

CytoSorbents Earnings

Data Unavailable

CytoSorbents Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.32 per share, and an increase next year of $0.16 per share.

* CytoSorbents stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.